Overview
Navneet Majhail is a Hematologist in Nashville, Tennessee. Dr. Majhail has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Majhail is currently accepting new patients.
His clinical research consists of co-authoring 320 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of T-Cell Lymphoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2410 Patterson St, Suite 500, Nashville, TN 37203
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
John Greer is a Hematologist in Nashville, Tennessee. Dr. Greer is rated as an Advanced provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Tennessee Oncology PLLC
Michael Byrne is a Hematologist and a Hematologist Oncology provider in Nashville, Tennessee. Dr. Byrne is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Byrne is currently accepting new patients.
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)Dr. Majhail isElite. Learn about Acute Myeloid Leukemia (AML).
- Graft Versus Host Disease (GvHD)
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Majhail isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia without Maturation
- Bone Marrow TransplantDr. Majhail isDistinguished. Learn about Bone Marrow Transplant.
- LeukemiaDr. Majhail isDistinguished. Learn about Leukemia.
- Multiple MyelomaDr. Majhail isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Majhail isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid LeukemiaDr. Majhail isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelomonocytic Leukemia (CMML)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Febrile NeutropeniaDr. Majhail isAdvanced. Learn about Febrile Neutropenia.
- MyelofibrosisDr. Majhail isAdvanced. Learn about Myelofibrosis.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Majhail isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Promyelocytic LeukemiaDr. Majhail isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Majhail isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Majhail isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Majhail isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- Anaplastic Large Cell LymphomaDr. Majhail isExperienced. Learn about Anaplastic Large Cell Lymphoma.